KPIs & Operating Metrics(New)
Growth Metrics

Bristol Myers Squibb (BMY) Operating Margin Growth (5y) (2014 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn
10 Gsk 88.34 Bn 83.66 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 122.00
Dec 31, 2025 9,970.00
Sep 30, 2025 -30.00
Jun 30, 2025 -245.00
Mar 31, 2025 3,623.00
Dec 31, 2024 -458.00
Sep 30, 2024 -343.00
Jun 30, 2024 -1,311.00
Mar 31, 2024 -12,439.00
Dec 31, 2023 -757.00
Sep 30, 2023 -1,248.00
Jun 30, 2023 1,037.00
Mar 31, 2023 -196.00
Dec 31, 2022 1,014.00
Sep 30, 2022 625.00
Jun 30, 2022 -108.00
Mar 31, 2022 -2,073.00
Dec 31, 2021 195.00
Sep 30, 2021 -631.00
Jun 30, 2021 -1,608.00
Mar 31, 2021 -1,654.00
Dec 31, 2020 -8,895.00
Sep 30, 2020 38.00
Jun 30, 2020 1,250.00
Mar 31, 2020 -5,166.00
Dec 31, 2019 -889.00
Sep 30, 2019 -737.00
Jun 30, 2019 1,084.00
Mar 31, 2019 217.00
Dec 31, 2018 734.00
Sep 30, 2018 1,790.00
Jun 30, 2018 -515.00
Mar 31, 2018 1,391.00
Dec 31, 2017 -316.00
Sep 30, 2017 5,258.00
Jun 30, 2017 -114.00
Mar 31, 2017 21.00
Dec 31, 2016 -1,027.00
Sep 30, 2016 -275.00
Jun 30, 2016 271.00
Mar 31, 2016 527.00
Dec 31, 2015 -3,175.00
Sep 30, 2015 -966.00
Jun 30, 2015 -2,969.00
Mar 31, 2015 1,184.00
Dec 31, 2014 -2,185.00
Sep 30, 2014 -515.00
Jun 30, 2014 -2,033.00
Mar 31, 2014 -25.00